SE8803472A - - Google Patents
Info
- Publication number
- SE8803472A SE8803472A SE8803472A SE8803472A SE8803472A SE 8803472 A SE8803472 A SE 8803472A SE 8803472 A SE8803472 A SE 8803472A SE 8803472 A SE8803472 A SE 8803472A SE 8803472 A SE8803472 A SE 8803472A
- Authority
- SE
- Sweden
- Prior art keywords
- treatment
- interferon
- gamma
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803472A SE462364B (sv) | 1988-09-30 | 1988-09-30 | Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos |
HU895542A HU206988B (en) | 1988-09-30 | 1989-09-27 | Process for producing pharmaceutical composition comprising gamma-interferon as active ingredient |
JP1510051A JP2895896B2 (ja) | 1988-09-30 | 1989-09-27 | 脈管狭窄の治療におけるγ―インターフェロンの使用 |
EP89850317A EP0367735B1 (en) | 1988-09-30 | 1989-09-27 | Use of gamma interferon in pharmaceutical preparations for the treatment of vascular stenosis |
KR1019900701144A KR0137017B1 (ko) | 1988-09-30 | 1989-09-27 | 감마-인터페론을 이용한 혈관 협착증의 치료방법 |
US07/671,786 US5208019A (en) | 1988-09-30 | 1989-09-27 | Use of gamma-interferon for the treatment of vascular stenosis |
DE89850317T DE68905438T2 (de) | 1988-09-30 | 1989-09-27 | Verwendung von Interferon-gamma in pharmazeutischen Zubereitungen zur Behandlung von Gefässstenose. |
AT89850317T ATE86869T1 (de) | 1988-09-30 | 1989-09-27 | Verwendung von interferon-gamma in pharmazeutischen zubereitungen zur behandlung von gefaessstenose. |
IL9179689A IL91796A (en) | 1988-09-30 | 1989-09-27 | Pharmacological preparations containing gamma interferon |
PCT/SE1989/000520 WO1990003189A1 (en) | 1988-09-30 | 1989-09-27 | Use of gamma-interferon for the treatment of vascular stenosis |
AU43051/89A AU623181B2 (en) | 1988-09-30 | 1989-09-27 | Use of gamma-interferon for the treatment of vascular stenosis |
DD89333072A DD288094A5 (de) | 1988-09-30 | 1989-09-28 | Verwendung von gamma-interferon zur behandlung von gefaessverengungen |
NZ230816A NZ230816A (en) | 1988-09-30 | 1989-09-28 | Gamma interferon, treatment of vascular stenosis |
CA000614859A CA1338722C (en) | 1988-09-30 | 1989-09-29 | Gamma-interferon for the treatment of vascular stenosis |
PT91863A PT91863B (pt) | 1988-09-30 | 1989-09-29 | Processo de preparacao de uma preparacao farmaceutica a base de gama-interferao |
IE312389A IE63874B1 (en) | 1988-09-30 | 1989-09-29 | Use of gamma-interferon for the treatment of vascular stenosis |
PH39308A PH26293A (en) | 1988-09-30 | 1989-09-29 | Use of gamma-interferon for the treatment of vascular stenosis |
DK199100562A DK174523B1 (da) | 1988-09-30 | 1991-03-27 | Anvendelse af gamma-interferon til fremstilling af et lægemiddel til behandling af vasculær stenosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803472A SE462364B (sv) | 1988-09-30 | 1988-09-30 | Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8803472A true SE8803472A (sv) | 1988-09-30 |
SE8803472D0 SE8803472D0 (sv) | 1988-09-30 |
SE462364B SE462364B (sv) | 1990-06-18 |
Family
ID=20373494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8803472A SE462364B (sv) | 1988-09-30 | 1988-09-30 | Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos |
Country Status (18)
Country | Link |
---|---|
US (1) | US5208019A (sv) |
EP (1) | EP0367735B1 (sv) |
JP (1) | JP2895896B2 (sv) |
KR (1) | KR0137017B1 (sv) |
AT (1) | ATE86869T1 (sv) |
AU (1) | AU623181B2 (sv) |
CA (1) | CA1338722C (sv) |
DD (1) | DD288094A5 (sv) |
DE (1) | DE68905438T2 (sv) |
DK (1) | DK174523B1 (sv) |
HU (1) | HU206988B (sv) |
IE (1) | IE63874B1 (sv) |
IL (1) | IL91796A (sv) |
NZ (1) | NZ230816A (sv) |
PH (1) | PH26293A (sv) |
PT (1) | PT91863B (sv) |
SE (1) | SE462364B (sv) |
WO (1) | WO1990003189A1 (sv) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CA2131550A1 (en) * | 1992-02-05 | 1993-08-19 | Andrew Zalewski | Interferon gene therapy for the treatment of vascular disorders |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US5770609A (en) * | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5957972A (en) * | 1992-09-29 | 1999-09-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening |
HU220969B1 (hu) * | 1993-01-07 | 2002-07-29 | Thomas Jefferson University | A C-MYC-re specifikus antiszensz oligonukleotid alkalmazása simaizomsejtek proliferációjának szabályozásában |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
ATE406909T1 (de) * | 1993-05-13 | 2008-09-15 | Poniard Pharmaceuticals Inc | Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind |
US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
US6323184B1 (en) | 1993-10-15 | 2001-11-27 | Thomas Jefferson University | Arteriovenous and venous graft treatments: methods and compositions |
US6133242A (en) * | 1993-10-15 | 2000-10-17 | Thomas Jefferson Univerisity | Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
US5449679A (en) * | 1994-07-29 | 1995-09-12 | Leonard; Robert J. | Process and products for reducing biological fluid levels of a lipid soluble waste |
US5665591A (en) * | 1994-12-06 | 1997-09-09 | Trustees Of Boston University | Regulation of smooth muscle cell proliferation |
US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
EP0797998A4 (en) * | 1995-11-17 | 2003-01-15 | Toray Industries | PROTECTION FOR ENDOTHEL CELLS |
US5681558A (en) * | 1995-11-30 | 1997-10-28 | Berlex Laboratories, Inc. | Method of using beta-interferons to treat restenosis |
ES2314786T3 (es) | 1998-04-02 | 2009-03-16 | Genentech, Inc. | Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca. |
US7524826B2 (en) * | 2000-04-14 | 2009-04-28 | Mcmaster University And Hamilton Health Sciences Corporation | Method of inhibiting the generation of active thrombin on the surface of a cell within an atherosclerotic plaque |
AU2002310922A1 (en) * | 2001-05-04 | 2002-11-18 | Institute Of Molecular And Cell Biology | Interferons in the treatment of ischemia |
AU2005211385B2 (en) | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3261761D1 (en) * | 1981-07-14 | 1985-02-14 | Efamol Ltd | Pharmaceutical and dietary composition when used for enhancement of 1-series pg production |
US5096705A (en) * | 1981-10-19 | 1992-03-17 | Genentech, Inc. | Human immune interferon |
US4454115A (en) * | 1981-10-23 | 1984-06-12 | Wisconsin Alumni Research Foundation | Method of reducing the level of low density lipoproteins in the serum of a patient |
US4483849A (en) * | 1983-01-07 | 1984-11-20 | Carter William A | Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product |
JPS6069037A (ja) * | 1983-09-26 | 1985-04-19 | Sunstar Inc | エリテマト−デス治療用外用剤 |
US4680175A (en) * | 1984-02-07 | 1987-07-14 | Interferon Sciences, Inc. | Interferon administration vehicles |
US4605555A (en) * | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
US4946674A (en) * | 1984-10-05 | 1990-08-07 | Bioferon Biochemische Substanzen Gmbh & Co. | Process for treatment of rheumatic diseases |
IL78444A (en) * | 1986-04-08 | 1992-05-25 | Yeda Res & Dev | Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody |
US5026544A (en) * | 1988-02-16 | 1991-06-25 | Board Of Reagents, The University Of Texas System | Methods and compositions for inhibiting the growth of neoplastic cells |
-
1988
- 1988-09-30 SE SE8803472A patent/SE462364B/sv not_active IP Right Cessation
-
1989
- 1989-09-27 EP EP89850317A patent/EP0367735B1/en not_active Expired - Lifetime
- 1989-09-27 HU HU895542A patent/HU206988B/hu not_active IP Right Cessation
- 1989-09-27 IL IL9179689A patent/IL91796A/en not_active IP Right Cessation
- 1989-09-27 AT AT89850317T patent/ATE86869T1/de not_active IP Right Cessation
- 1989-09-27 WO PCT/SE1989/000520 patent/WO1990003189A1/en active Application Filing
- 1989-09-27 US US07/671,786 patent/US5208019A/en not_active Expired - Lifetime
- 1989-09-27 JP JP1510051A patent/JP2895896B2/ja not_active Expired - Lifetime
- 1989-09-27 AU AU43051/89A patent/AU623181B2/en not_active Expired
- 1989-09-27 DE DE89850317T patent/DE68905438T2/de not_active Expired - Lifetime
- 1989-09-27 KR KR1019900701144A patent/KR0137017B1/ko not_active IP Right Cessation
- 1989-09-28 NZ NZ230816A patent/NZ230816A/en unknown
- 1989-09-28 DD DD89333072A patent/DD288094A5/de unknown
- 1989-09-29 IE IE312389A patent/IE63874B1/en not_active IP Right Cessation
- 1989-09-29 CA CA000614859A patent/CA1338722C/en not_active Expired - Lifetime
- 1989-09-29 PH PH39308A patent/PH26293A/en unknown
- 1989-09-29 PT PT91863A patent/PT91863B/pt not_active IP Right Cessation
-
1991
- 1991-03-27 DK DK199100562A patent/DK174523B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUT57063A (en) | 1991-11-28 |
ATE86869T1 (de) | 1993-04-15 |
IL91796A (en) | 1994-10-07 |
IL91796A0 (en) | 1990-06-10 |
PH26293A (en) | 1992-04-10 |
EP0367735B1 (en) | 1993-03-17 |
JP2895896B2 (ja) | 1999-05-24 |
DE68905438D1 (de) | 1993-04-22 |
SE462364B (sv) | 1990-06-18 |
DD288094A5 (de) | 1991-03-21 |
PT91863B (pt) | 1995-05-31 |
DE68905438T2 (de) | 1993-09-30 |
SE8803472D0 (sv) | 1988-09-30 |
DK56291D0 (da) | 1991-03-27 |
NZ230816A (en) | 1997-06-24 |
AU623181B2 (en) | 1992-05-07 |
JPH04500966A (ja) | 1992-02-20 |
DK56291A (da) | 1991-05-24 |
US5208019A (en) | 1993-05-04 |
HU895542D0 (en) | 1991-10-28 |
WO1990003189A1 (en) | 1990-04-05 |
CA1338722C (en) | 1996-11-19 |
AU4305189A (en) | 1990-04-18 |
DK174523B1 (da) | 2003-05-12 |
KR0137017B1 (ko) | 1998-04-25 |
EP0367735A1 (en) | 1990-05-09 |
PT91863A (pt) | 1990-03-30 |
IE893123L (en) | 1990-03-30 |
KR900701308A (ko) | 1990-12-01 |
IE63874B1 (en) | 1995-06-14 |
HU206988B (en) | 1993-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8803472A (sv) | ||
WO1988006026A3 (en) | Internal prosthesis for the substitution of a part of the human body particularly in vascular surgery | |
EP0509317A3 (en) | Use of droloxifene in the treatment of bone diseases | |
ATE186460T1 (de) | Methode zur verhinderung von restenosierung nach rekanalisierung von körpergefässen | |
HUT64231A (en) | Process for the production of medical preparatives containing heparing and rapamycin for the preventing and treatment of blood-vessel diseases caused by hyper proliferation | |
EP0376251A3 (en) | An anticoagulant substance obtained from urine | |
DK0668077T3 (da) | Produkter, som indeholder G-CSF og TNF-bindende protein | |
NO924066D0 (no) | Terapeutisk middel | |
HU911756D0 (en) | Process for the production of medical preparations containing magnesium-pyridoxal-5'-phosphate-glutaminate, for the preventing of arterial diseases | |
AU6178094A (en) | Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis | |
NO308856B1 (no) | Dermatansulfater og salter av disse | |
DK0590321T3 (da) | Anvendelse af NADH og NADPH til fremstilling af et lægemiddel til behandling af Alzheimers sygdom | |
EP1222854A4 (en) | PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH BLOOD COAGULATION | |
ATE164521T1 (de) | Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose | |
TW223589B (sv) | ||
ID23176A (id) | Metoda untuk mengobati gangguan pembuluh darah | |
UA37249C2 (uk) | Спосіб інгібування стенозу та/або рестенозу (варіанти), спосіб інгібування рестенозу після проведення операції на коронарній артерії у людини (варіанти), спосіб зниження ймовірності виникнення чи запобігання негострих ішемічних ускладнень при ангіопластиці у людини | |
HU9200025D0 (en) | Medical preparations for treating depression | |
DE68906437D1 (de) | L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. | |
DK417889D0 (da) | Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme | |
DE69001988D1 (de) | Behandlung des schocks mit cyclodextrin und dessen derivaten. | |
EP0282844A3 (en) | Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries | |
ITVR930047V0 (it) | Letto per la terapia di fluidizzazione in particolare per il decupito o la cura di ustioni | |
DK1889D0 (da) | Kombineret behandling af arteria femoralis superficialis okklusion med perkutan transluminal angioplastik og lokalt indelukket rekombineret plasminogen aktivator. 4 lumen dobbelt ballon kateter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8803472-3 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8803472-3 Format of ref document f/p: F |